Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
324 studies found for:    Open Studies | "Esophageal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Other: Biomarkers Testing;   Other: Functional Imaging analysis
22 Recruiting Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Radiation: Radiotherapy with simultaneous modulated accelerated boost;   Radiation: Standard dose radiotherapy;   Drug: PF
23 Recruiting Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: Adjuvant chemotherapy (Paclitaxel and Cisplatin);   Radiation: Adjuvant radiotherapy;   Other: Control group (Surgery alone)
24 Recruiting 4D FDG PET in Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Other: 4d PET-CT
25 Not yet recruiting Chemoradiotherapy for Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Carboplatin and Taxol (paclitaxel);   Radiation: External Beam Radiation
26 Recruiting Radiation Dose Escalation in Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Radiation: radiochemotherapy 1;   Radiation: radiochemotherapy 2;   Radiation: radiochemotherapy 3;   Radiation: radiochemotherapy 4;   Radiation: radiochemotherapy 5;   Radiation: radiochemotherapy 6
27 Recruiting MR/PET in the Evaluation of Patients With Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Device: The imaging biomarkers determined by MR-PET
28 Recruiting Study of Apatinib in Metastatic Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Drug: Apatinib
29 Not yet recruiting Induction Chemotherapy for Locally Advanced Esophageal Cancer
Condition: Esophageal Carcinoma
Interventions: Drug: mFOLFOX6;   Combination Product: Chemoradiation
30 Recruiting PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer
Condition: Esophageal Tumor
Intervention:
31 Recruiting Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Radiation: Radiotherapy
32 Recruiting Early Integration of Palliative Care in Esophageal Cancer Patients
Condition: Esophageal Cancer
Intervention: Other: Early Palliative Care
33 Recruiting Feasibility Study of Fiducial Markers in Oesophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Device: Fiducial markers
34 Recruiting A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC
Condition: Esophageal Neoplasms
Intervention: Drug: Sodium Glycididazole
35 Recruiting A Study of Durvalumab (MEDI4736) in Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Drug: Durvalumab
36 Recruiting Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Device: Balloon dilation
37 Recruiting A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC
Condition: Esophageal Neoplasms
Intervention: Drug: Sodium Glycididazole
38 Recruiting Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Icotinib;   Radiation: Thoracic radiotherapy
39 Recruiting A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC
Condition: Esophageal Neoplasms
Interventions: Drug: Sodium Glycididazole;   Drug: Placebo
40 Recruiting Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Nivolumab;   Drug: Docetaxel/Paclitaxel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.